An update from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has concluded its share buyback program, which began on November 12, 2024, and was aimed at purchasing shares to support stock options and performance share plans for management. The company purchased a total of 1,498,369 shares, representing 0.716% of its share capital, for a total value of 79,476,342.59 Euros. As of March 31, 2025, Recordati holds 3,130,654 own shares, equivalent to 1.497% of its share capital.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as in rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions with over 4,450 employees.
YTD Price Performance: 4.40%
Average Trading Volume: 32,855
Technical Sentiment Signal: Sell
Current Market Cap: €10.79B
Learn more about REC stock on TipRanks’ Stock Analysis page.